Verma Abhimanyu 4
4 · SOPHiA GENETICS SA · Filed Apr 3, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CTO Abhimanyu Verma Receives RSU/Option Awards
What Happened
Abhimanyu Verma, Chief Technology Officer of SOPHiA GENETICS SA (SOPH), received equity awards under the company's 2021 Equity Incentive Plan on April 2, 2026. The Form 4 reports acquisition code "A" for (1) 82,136 restricted stock units (RSUs) at $0.00 and (2) 119,760 derivative awards (appears to be stock options or similar) at $0.00 — a total of 201,896 awards. The filing shows no cash paid for these grants (typical for awarded equity).
Key Details
- Transaction date: 2026-04-02; Form filed: 2026-04-03 (timely).
- Reported prices: $0.00 for both items (standard reporting for grants/awards).
- Total awards: 82,136 RSUs + 119,760 derivative awards = 201,896 awards.
- Vesting (per footnotes): RSUs — 25% vest on Apr 2, 2027, then quarterly through Apr 2, 2030 (F1). Derivative/option — 25% vests on Apr 2, 2027, then monthly through Apr 2, 2030 (F2).
- Shares owned following the transaction: not disclosed in the provided filing excerpt.
- No indication of a sale or exercise; these are compensation awards (not a market sale). No late filing noted.
Context
RSU grants and option-type awards are typical long-term compensation for executives and vest over time contingent on continued service; they do not reflect an immediate purchase or sale of shares. The derivative award will only convert to exercisable shares according to its vesting schedule, and any future exercise or sale would generate separate Form 4 filings.
Insider Transaction Report
- Award
Ordinary Shares
[F1]2026-04-02+82,136→ 82,136 total - Award
Share Option (Right to Buy)
[F2]2026-04-02+119,760→ 119,760 totalExercise: $5.04Exp: 2036-04-02→ Ordinary Shares (119,760 underlying)
Footnotes (2)
- [F1]Represents a restricted stock unit ("RSU") grant made under the Issuer's 2021 Equity Incentive Plan. Each RSU represents a contingent right to receive one ordinary share of the Issuer, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date. 25% of the RSUs will vest on April 2, 2027, and the remaining 75% will vest in equal quarterly installments through April 2, 2030.
- [F2]The share option vests and becomes exercisable as to 25% of the ordinary shares on April 2, 2027, and then in equal monthly installments through April 2, 2030.